VVOS Annual EBIT
-$17.30 M
+$7.74 M+30.90%
31 December 2023
Summary:
As of January 19, 2025, VVOS annual earnings before interest & taxes is -$17.30 million, with the most recent change of +$7.74 million (+30.90%) on December 31, 2023. During the last 3 years, it has fallen by -$5.33 million (-44.60%). VVOS annual EBIT is now -107.48% below its all-time high of -$7.73 million.VVOS EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VVOS Quarterly EBIT
-$2.65 M
-$709.00 K-36.62%
30 September 2024
Summary:
As of January 19, 2025, VVOS quarterly earnings before interest & taxes is -$2.65 million, with the most recent change of -$709.00 thousand (-36.62%) on September 30, 2024. Over the past year, it has increased by +$1.49 million (+36.00%). VVOS quarterly EBIT is now -89.52% below its all-time high of -$1.40 million, reached on June 30, 2020.VVOS Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VVOS TTM EBIT
-$12.50 M
+$995.00 K+7.37%
30 September 2024
Summary:
As of January 19, 2025, VVOS TTM earnings before interest & taxes is -$12.50 million, with the most recent change of +$995.00 thousand (+7.37%) on September 30, 2024. Over the past year, it has increased by +$4.80 million (+27.73%). VVOS TTM EBIT is now -309.04% below its all-time high of -$3.06 million, reached on September 30, 2019.VVOS TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VVOS EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +30.9% | +36.0% | +27.7% |
| 3 y3 years | -44.6% | +51.9% | +34.9% |
| 5 y5 years | -107.5% | +22.3% | +2.6% |
VVOS EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +30.9% | -36.6% | +63.8% | at high | +52.7% |
| 5 y | 5-year | -62.9% | +30.9% | -89.5% | +63.8% | -122.3% | +52.7% |
| alltime | all time | -107.5% | +30.9% | -89.5% | +63.8% | -309.0% | +52.7% |
Vivos Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.65 M(+36.6%) | -$12.50 M(-7.4%) |
| June 2024 | - | -$1.94 M(-48.9%) | -$13.49 M(-16.1%) |
| Mar 2024 | - | -$3.79 M(-8.4%) | -$16.07 M(-7.1%) |
| Dec 2023 | -$17.30 M(-30.9%) | -$4.13 M(+13.5%) | -$17.30 M(-10.0%) |
| Sept 2023 | - | -$3.64 M(-19.4%) | -$19.23 M(-8.4%) |
| June 2023 | - | -$4.52 M(-9.8%) | -$20.99 M(-10.4%) |
| Mar 2023 | - | -$5.00 M(-17.5%) | -$23.44 M(-6.5%) |
| Dec 2022 | -$25.03 M(+23.5%) | -$6.06 M(+12.1%) | -$25.07 M(-4.7%) |
| Sept 2022 | - | -$5.41 M(-22.4%) | -$26.31 M(-0.4%) |
| June 2022 | - | -$6.96 M(+4.9%) | -$26.41 M(+12.4%) |
| Mar 2022 | - | -$6.64 M(-9.1%) | -$23.51 M(+15.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$20.27 M(+69.5%) | -$7.30 M(+32.7%) | -$20.27 M(+5.6%) |
| Sept 2021 | - | -$5.50 M(+35.5%) | -$19.20 M(+23.9%) |
| June 2021 | - | -$4.06 M(+19.2%) | -$15.50 M(+20.8%) |
| Mar 2021 | - | -$3.41 M(-45.4%) | -$12.83 M(+7.3%) |
| Dec 2020 | -$11.96 M(+12.7%) | -$6.23 M(+247.0%) | -$11.96 M(+44.2%) |
| Sept 2020 | - | -$1.80 M(+28.7%) | -$8.30 M(-13.2%) |
| June 2020 | - | -$1.40 M(-45.0%) | -$9.56 M(+17.1%) |
| Mar 2020 | - | -$2.54 M(-1.2%) | -$8.16 M(+45.1%) |
| Dec 2019 | -$10.62 M(+27.4%) | -$2.57 M(-16.0%) | -$5.62 M(+84.0%) |
| Sept 2019 | - | -$3.06 M | -$3.06 M |
| Dec 2018 | -$8.34 M | - | - |
FAQ
- What is Vivos Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Vivos Therapeutics?
- What is Vivos Therapeutics annual EBIT year-on-year change?
- What is Vivos Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Vivos Therapeutics?
- What is Vivos Therapeutics quarterly EBIT year-on-year change?
- What is Vivos Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Vivos Therapeutics?
- What is Vivos Therapeutics TTM EBIT year-on-year change?
What is Vivos Therapeutics annual earnings before interest & taxes?
The current annual EBIT of VVOS is -$17.30 M
What is the all time high annual EBIT for Vivos Therapeutics?
Vivos Therapeutics all-time high annual earnings before interest & taxes is -$7.73 M
What is Vivos Therapeutics annual EBIT year-on-year change?
Over the past year, VVOS annual earnings before interest & taxes has changed by +$7.74 M (+30.90%)
What is Vivos Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of VVOS is -$2.65 M
What is the all time high quarterly EBIT for Vivos Therapeutics?
Vivos Therapeutics all-time high quarterly earnings before interest & taxes is -$1.40 M
What is Vivos Therapeutics quarterly EBIT year-on-year change?
Over the past year, VVOS quarterly earnings before interest & taxes has changed by +$1.49 M (+36.00%)
What is Vivos Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of VVOS is -$12.50 M
What is the all time high TTM EBIT for Vivos Therapeutics?
Vivos Therapeutics all-time high TTM earnings before interest & taxes is -$3.06 M
What is Vivos Therapeutics TTM EBIT year-on-year change?
Over the past year, VVOS TTM earnings before interest & taxes has changed by +$4.80 M (+27.73%)